These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10796514)

  • 21. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.
    Bott J; Carroll MP; Conway JH; Keilty SE; Ward EM; Brown AM; Paul EA; Elliott MW; Godfrey RC; Wedzicha JA; Moxham J
    Lancet; 1993 Jun; 341(8860):1555-7. PubMed ID: 8099639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beclometasone for chronic obstructive pulmonary disease.
    De Coster DA; Jones M; Thakrar N
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009769. PubMed ID: 24105424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Appleton S; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Doxapram in stable obstructive chronic respiratory insufficiency. A prospective study on 15 cases (author's transl)].
    Mornet M
    Poumon Coeur; 1980; 36(5):349-52. PubMed ID: 6779273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
    Nannini L; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease.
    Ram FS; Lightowler JV; Wedzicha JA
    Cochrane Database Syst Rev; 2003; (1):CD004104. PubMed ID: 12535509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory stimulation with intravenous doxapram in respiratory failure. A double-blind co-operative study.
    Moser KM; Luchsinger PC; Adamson JS; McMahon SM; Schlueter DP; Spivack M; Weg JG
    N Engl J Med; 1973 Mar; 288(9):427-31. PubMed ID: 4567320
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of almitrine on arterial gases in patients with chronic respiratory insufficiency. Comparison with doxapram. Preliminary results].
    Marcq M; Gepts L; Erven W; Minette A
    Rev Inst Hyg Mines (Hasselt); 1979; 34(3):141-9. PubMed ID: 45211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Evans DJ; Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxapram reversal of respiratory failure in a patient refusing assisted ventilation.
    McNamara RM; Euerle BD
    Ann Emerg Med; 1994 Oct; 24(4):751-4. PubMed ID: 8092607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Wang W; Morley C; Soltani A; Wood-Baker R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD006897. PubMed ID: 21975757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of doxapram on the response to hypercapnia: application to weaning from artificial ventilation in chronic obstructive respiratory insufficiency].
    Pourriat JL; Baud M; Lamberto C; Hoang P; Aitkaci F; Vasseur B; Cupa M
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R264. PubMed ID: 2604214
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma.
    Ram FS; Wellington S; Rowe BH; Wedzicha JA
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004360. PubMed ID: 15674944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation.
    Appleton S; Poole P; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2002; (3):CD001104. PubMed ID: 12137617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventilatory and pulmonary hemodynamic response to the respiratory stimulant doxapram in chronic bronchitis.
    Conti F; Bertoli L; Bertoli M; Mantero O
    Pharmacol Res Commun; 1976 Jun; 8(3):243-51. PubMed ID: 800260
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to a respiratory stimulant (doxapram) in severe respiratory failure.
    Riordan JF; Sillett RW; McNicol MW
    Br J Dis Chest; 1974 Jan; 68(1):39-45. PubMed ID: 4819772
    [No Abstract]   [Full Text] [Related]  

  • 39. Doxapram in respiratory failure. A case presentation.
    Kwik RS
    Middle East J Anaesthesiol; 1980 Jun; 5(7):495-9. PubMed ID: 7464569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards evidence based emergency medicine:PRIVATE best BETs from the Manchester Royal Infirmary. Bet 2: doxapram resurrected? Weak evidence of efficacy suggests a potential use in patients ineligible for non-invasive ventilation.
    Emerg Med J; 2012 Jan; 29(1):78-80. PubMed ID: 22186269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.